Financhill
Sell
41

JBLU Quote, Financials, Valuation and Earnings

Last price:
$7.44
Seasonality move :
-5.7%
Day range:
$7.18 - $7.70
52-week range:
$4.50 - $8.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.27x
P/B ratio:
0.98x
Volume:
23M
Avg. volume:
19.3M
1-year change:
32.3%
Market cap:
$2.6B
Revenue:
$9.6B
EPS (TTM):
-$2.52
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $8.1B $3B $6B $9.2B $9.6B
Revenue Growth (YoY) 5.69% -63.47% 104.16% 51.7% 4.99%
 
Cost of Revenues $5.9B $4.1B $5.7B $7.7B $7.8B
Gross Profit $2.2B -$1.1B $350M $1.5B $1.8B
Gross Profit Margin 27.3% -38.05% 5.8% 16.07% 18.53%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $290M $110M $183M $289M $316M
Other Inc / (Exp) $1M $260M $825M -$125M -$180M
Operating Expenses $1.4B $872M $1.3B $1.7B $1.8B
Operating Income $814M -$2B -$913M -$185M -$33M
 
Net Interest Expenses $47M $156M $175M $127M $121M
EBT. Incl. Unusual Items $768M -$1.9B -$263M -$437M -$334M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $199M -$539M -$81M -$75M -$24M
Net Income to Company $569M -$1.4B -$182M -$362M -$310M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $569M -$1.4B -$182M -$362M -$310M
 
Basic EPS (Cont. Ops) $1.92 -$4.88 -$0.57 -$1.12 -$0.93
Diluted EPS (Cont. Ops) $1.91 -$4.88 -$0.57 -$1.12 -$0.93
Weighted Average Basic Share $296.6M $277.5M $318M $323.6M $332.9M
Weighted Average Diluted Share $298.4M $279.5M $318M $323.6M $332.9M
 
EBITDA $1.4B -$1.2B $469M $314M $497M
EBIT $847M -$1.7B -$71M -$271M -$124M
 
Revenue (Reported) $8.1B $3B $6B $9.2B $9.6B
Operating Income (Reported) $814M -$2B -$913M -$185M -$33M
Operating Income (Adjusted) $847M -$1.7B -$71M -$271M -$124M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $492M $2B $2.6B $2.4B $2.4B
Revenue Growth (YoY) -76.41% 300.81% 29.92% -8.16% 0.51%
 
Cost of Revenues $929M $1.6B $2B $2B $1.9B
Gross Profit -$437M $357M $576M $330M $432M
Gross Profit Margin -88.82% 18.1% 22.48% 14.03% 18.27%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $24M $60M $81M $80M $81M
Other Inc / (Exp) $112M $228M -$14M -$22M -$2M
Operating Expenses $191M $357M $424M $453M $443M
Operating Income -$628M -- $152M -$123M -$11M
 
Net Interest Expenses $62M $38M $33M $29M $67M
EBT. Incl. Unusual Items -$578M $190M $105M -$174M -$78M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$185M $60M $48M -$21M -$18M
Net Income to Company -$393M $130M $57M -$153M -$60M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$393M $130M $57M -$153M -$60M
 
Basic EPS (Cont. Ops) -$1.44 $0.41 $0.18 -$0.46 -$0.17
Diluted EPS (Cont. Ops) -$1.44 $0.40 $0.18 -$0.46 -$0.17
Weighted Average Basic Share $272.4M $318M $323.9M $333.3M $346.9M
Weighted Average Diluted Share $272.4M $321.3M $325M $333.3M $346.9M
 
EBITDA -$388M $372M $296M $30M $184M
EBIT -$516M $232M $149M -$126M $19M
 
Revenue (Reported) $492M $2B $2.6B $2.4B $2.4B
Operating Income (Reported) -$628M -- $152M -$123M -$11M
Operating Income (Adjusted) -$516M $232M $149M -$126M $19M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.3B $4.9B $8.6B $9.7B $9.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.6B $5.1B $7.4B $7.9B $7.6B
Gross Profit -$254M -$199M $1.2B $1.8B $1.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $160M $156M $269M $311M $324M
Other Inc / (Exp) -$90M $602M -$80M -$211M -$600M
Operating Expenses $689M $838M $1.6B $1.7B $1.8B
Operating Income -$943M -$1B -$395M $105M -$148M
 
Net Interest Expenses $129M $177M $132M $112M $178M
EBT. Incl. Unusual Items -$1.2B -$612M -$607M -$218M -$924M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$342M -$186M -$92M -$35M -$70M
Net Income to Company -$820M -$426M -$515M -$183M -$854M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$820M -$426M -$515M -$183M -$854M
 
Basic EPS (Cont. Ops) -$3.03 -$1.51 -$1.59 -$0.56 -$2.52
Diluted EPS (Cont. Ops) -$3.03 -$1.52 -$1.59 -$0.56 -$2.52
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$459M $126M $130M $570M $6M
EBIT -$1B -$400M -$447M -$42M -$640M
 
Revenue (Reported) $4.3B $4.9B $8.6B $9.7B $9.3B
Operating Income (Reported) -$943M -$1B -$395M $105M -$148M
Operating Income (Adjusted) -$1B -$400M -$447M -$42M -$640M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.3B $4.2B $6.7B $7.3B $7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.1B $4.1B $5.8B $6B $5.8B
Gross Profit -$829M $96M $957M $1.3B $1.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $85M $130M $216M $238M $245M
Other Inc / (Exp) -$90M $556M -$62M -$148M -$568M
Operating Expenses $341M $610M $1.2B $1.3B $1.3B
Operating Income -$1.2B -$514M -$284M $6M -$110M
 
Net Interest Expenses $122M $142M $98M $82M $138M
EBT. Incl. Unusual Items -$1.4B -$100M -$444M -$224M -$814M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$401M -$47M -$58M -$17M -$63M
Net Income to Company -$981M -$53M -$386M -$207M -$751M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$981M -$53M -$386M -$207M -$751M
 
Basic EPS (Cont. Ops) -$3.59 -$0.17 -$1.19 -$0.63 -$2.21
Diluted EPS (Cont. Ops) -$3.59 -$0.18 -$1.19 -$0.63 -$2.21
Weighted Average Basic Share $821.3M $952M $967.5M $992.8M $1B
Weighted Average Diluted Share $821.3M $959.1M $968.6M $994.5M $1B
 
EBITDA -$851M $452M $112M $369M -$122M
EBIT -$1.3B $54M -$323M -$93M -$609M
 
Revenue (Reported) $2.3B $4.2B $6.7B $7.3B $7B
Operating Income (Reported) -$1.2B -$514M -$284M $6M -$110M
Operating Income (Adjusted) -$1.3B $54M -$323M -$93M -$609M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $959M $1.9B $2B $1B $1.2B
Short Term Investments $369M $1.1B $824M $350M $401M
Accounts Receivable, Net $231M $98M $207M $317M $336M
Inventory $81M $71M $74M $87M $109M
Prepaid Expenses -- -- -- -- --
Other Current Assets $146M $123M $122M $120M $148M
Total Current Assets $1.8B $3.3B $3.2B $1.9B $2.2B
 
Property Plant And Equipment $9.5B $9.2B $9.5B $9.8B $10.3B
Long-Term Investments $3M $2M $39M $172M $163M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $362M $595M $516M $852M $913M
Total Assets $11.9B $13.4B $13.6B $13B $13.9B
 
Accounts Payable $401M $365M $499M $532M $641M
Accrued Expenses $671M $624M $839M $984M $1.1B
Current Portion Of Long-Term Debt $344M $450M $355M $554M $307M
Current Portion Of Capital Lease Obligations $128M $113M $106M $97M $117M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.7B $2.7B $3.4B $3.7B $3.6B
 
Long-Term Debt $2B $4.4B $3.7B $3.1B $4.4B
Capital Leases -- -- -- -- --
Total Liabilities $7.1B $9.5B $9.8B $9.5B $10.5B
 
Common Stock $4M $5M $5M $5M $5M
Other Common Equity Adj -- -- -- -- -$4M
Common Equity $4.8B $4B $3.8B $3.6B $3.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.8B $4B $3.8B $3.6B $3.3B
 
Total Liabilities and Equity $11.9B $13.4B $13.6B $13B $13.9B
Cash and Short Terms $1.3B $3.1B $2.8B $1.4B $1.6B
Total Debt $2.3B $4.9B $4B $3.6B $4.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.5B $2.2B $1.4B $973M $2.6B
Short Term Investments $566M $1.1B $692M $409M $1.4B
Accounts Receivable, Net $91M $210M $298M $329M $282M
Inventory $70M $64M $79M $97M $140M
Prepaid Expenses -- -- -- -- --
Other Current Assets $275M $123M $141M $162M $125M
Total Current Assets $3.5B $3.7B $2.6B $2B $4.6B
 
Property Plant And Equipment $9.2B $9.5B $9.8B $10B $11B
Long-Term Investments $3M $1M $175M $166M $94M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $767M $551M $536M $886M $633M
Total Assets $13.4B $14.1B $13.3B $13.4B $16.6B
 
Accounts Payable $407M $575M $600M $691M $612M
Accrued Expenses $635M $813M $931M $1.1B $1.2B
Current Portion Of Long-Term Debt $400M $391M $524M $272M $363M
Current Portion Of Capital Lease Obligations $113M $108M $103M $115M $99M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.8B $3.6B $3.9B $3.7B $3.8B
 
Long-Term Debt $4.4B $3.8B $3.2B $3.7B $7.9B
Capital Leases -- -- -- -- --
Total Liabilities $9.7B $10.1B $9.8B $10B $14B
 
Common Stock $4M $5M $5M $5M $5M
Other Common Equity Adj -- -- -- $4M -$3M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $3.7B $3.9B $3.5B $3.4B $2.6B
 
Total Liabilities and Equity $13.4B $14.1B $13.3B $13.4B $16.6B
Cash and Short Terms $3B $3.3B $2.1B $1.4B $4B
Total Debt $4.8B $4.2B $3.8B $4B $8.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $569M -$1.4B -$182M -$362M -$310M
Depreciation & Amoritzation $525M $535M $540M $585M $621M
Stock-Based Compensation $31M $28M $28M $30M $39M
Change in Accounts Receivable -$3M $144M -$46M -$111M -$3M
Change in Inventories $188M $52M $138M $201M $67M
Cash From Operations $1.4B -$683M $1.6B $379M $400M
 
Capital Expenditures $1.2B $791M $995M $923M $1.2B
Cash Acquisitions -- -- -- -$297M -$131M
Cash From Investing -$1.1B -$1.3B -$704M -$908M -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $981M $3.9B $1B -- $1.4B
Long-Term Debt Repaid -$323M -$1.4B -$1.9B -$369M -$347M
Repurchase of Common Stock -$542M -$167M -$8M -$6M -$4M
Other Financing Activities -$2M -$1M -- -$37M -$4M
Cash From Financing $165M $3B -$830M -$360M $1.1B
 
Beginning Cash (CF) $533M $1B $2B $2.1B $1.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $485M $951M $108M -$889M $129M
Ending Cash (CF) $1B $2B $2.1B $1.2B $1.3B
 
Levered Free Cash Flow $293M -$1.5B $647M -$544M -$806M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$393M $130M $57M -$153M -$60M
Depreciation & Amoritzation $128M $140M $147M $156M $165M
Stock-Based Compensation $5M $6M $7M $9M $9M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$446M $97M $22M -$177M -$29M
 
Capital Expenditures $162M $263M $260M $316M $285M
Cash Acquisitions -- -- -$25M -$32M --
Cash From Investing -$180M -$13M -$162M -$552M -$1.5B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.1B -- -- $295M $3.3B
Long-Term Debt Repaid -$1.1B -$294M -$66M -$54M -$465M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- $4M
Cash From Financing $60M -$294M -$66M $241M $2.9B
 
Beginning Cash (CF) $3.1B $2.5B $1.7B $1.6B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$566M -$210M -$206M -$488M $1.4B
Ending Cash (CF) $2.6B $2.3B $1.5B $1.1B $2.8B
 
Levered Free Cash Flow -$608M -$166M -$238M -$493M -$314M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$820M -$426M -$515M -$183M -$854M
Depreciation & Amoritzation $547M $526M $577M $612M $646M
Stock-Based Compensation $27M $31M $30M $36M $38M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $28M $1.3B $208M $544M $75M
 
Capital Expenditures $1.1B $998M $791M $1.1B $1.6B
Cash Acquisitions -- -- -$25M -$370M -$55M
Cash From Investing -$1.1B -$1.5B -$616M -$1.2B -$2.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $4.5B $1.1B -- $601M $4.9B
Long-Term Debt Repaid -$1.3B -$1.9B -$372M -$368M -$724M
Repurchase of Common Stock -$328M -$7M -$7M -$3M -$6M
Other Financing Activities -- -$2M -- -- --
Cash From Financing $2.9B -$123M -$360M $282M $4.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.8B -$327M -$768M -$362M $1.7B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1B $297M -$583M -$553M -$1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$981M -$53M -$386M -$207M -$751M
Depreciation & Amoritzation $407M $398M $435M $462M $487M
Stock-Based Compensation $20M $23M $25M $31M $30M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$223M $1.8B $321M $486M $161M
 
Capital Expenditures $596M $803M $599M $773M $1.2B
Cash Acquisitions -- -- -$25M -$98M -$22M
Cash From Investing -$585M -$735M -$647M -$927M -$2.2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.8B $1B -- $601M $4.1B
Long-Term Debt Repaid -$1.3B -$1.8B -$255M -$254M -$631M
Repurchase of Common Stock -$167M -$7M -$6M -$3M -$5M
Other Financing Activities -- -$1M -$35M -- --
Cash From Financing $2.4B -$737M -$267M $375M $3.5B
 
Beginning Cash (CF) $5.8B $6.8B $5.7B $4.3B $4.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $283M -$593M -$66M $1.5B
Ending Cash (CF) $7.4B $7.1B $5.1B $4.2B $5.6B
 
Levered Free Cash Flow -$819M $952M -$278M -$287M -$1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock